NCT00242281View on ClinicalTrials.gov

APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

July 31, 2006

Conditions
Sore ThroatPharyngitisTonsillitis
Interventions
DRUG

APC-111 MP Tablet, 775 mg

Trial Locations (41)

Unknown

Birmingham

Tallassee

Phoenix

Carmichael

Laguna Niguel

San Luis Obispo

Littleton

DeLand

Conyers

Boise

Overland Park

Topeka

Wichitia

Bardstown

Milford

New Bedford

Kalamazoo

Butte

Omaha

Johnson City

Burlington

Simpsonville

Canfield

North Wales

Scotland

Shippensburg

Bristol

Kingsport

San Antonio

Bountiful

Salt Lake City

West Jordan

Newport News

Edmonds

Wenatchee

Coquitlam

Fort Erie

Markham

Toronto

Saint-Jermone

Sherbrooke

Sponsors
All Listed Sponsors
lead

Advancis Pharmaceutical Corporation

INDUSTRY

NCT00242281 - APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat | Biotech Hunter | Biotech Hunter